Diets that differ in their FODMAP content alter the colonic luminal microenvironment.

PubWeight™: 1.54‹?› | Rank: Top 4%

🔗 View Article (PMID 25016597)

Published in Gut on July 12, 2014

Authors

Emma P Halmos1, Claus T Christophersen2, Anthony R Bird2, Susan J Shepherd3, Peter R Gibson1, Jane G Muir1

Author Affiliations

1: Department of Gastroenterology, Eastern Health Clinical School, Monash University, Box Hill, Victoria, Australia Department of Gastroenterology, Central Clinical School, Monash University, Melbourne, Victoria, Australia.
2: Food Futures National Research Flagship, Commonwealth Scientific and Industrial Research Organisation, Food, Animal and Health Sciences, Adelaide, South Australia, Australia.
3: Department of Gastroenterology, Eastern Health Clinical School, Monash University, Box Hill, Victoria, Australia.

Associated clinical trials:

SCD vs. Mediterranean Diet Therapy in Ulcerative Colitis | NCT04398550

Articles citing this

Randomised clinical trial: gut microbiome biomarkers are associated with clinical response to a low FODMAP diet in children with the irritable bowel syndrome. Aliment Pharmacol Ther (2015) 2.87

Relationship Between Microbiota of the Colonic Mucosa vs Feces and Symptoms, Colonic Transit, and Methane Production in Female Patients With Chronic Constipation. Gastroenterology (2015) 1.56

The gut microbiome in health and in disease. Curr Opin Gastroenterol (2015) 1.33

Intestinal Short Chain Fatty Acids and their Link with Diet and Human Health. Front Microbiol (2016) 1.20

Irritable bowel syndrome. Nat Rev Dis Prim (2016) 1.14

Intestinal microbiota and diet in IBS: causes, consequences, or epiphenomena? Am J Gastroenterol (2015) 1.13

Does a diet low in FODMAPs reduce symptoms associated with functional gastrointestinal disorders? A comprehensive systematic review and meta-analysis. Eur J Nutr (2015) 1.07

Food: The Main Course to Wellness and Illness in Patients With Irritable Bowel Syndrome. Am J Gastroenterol (2016) 1.04

Non-Celiac Gluten Sensitivity Has Narrowed the Spectrum of Irritable Bowel Syndrome: A Double-Blind Randomized Placebo-Controlled Trial. Nutrients (2015) 1.04

Underlying molecular and cellular mechanisms in childhood irritable bowel syndrome. Mol Cell Pediatr (2016) 0.94

Review article: dietary fibre-microbiota interactions. Aliment Pharmacol Ther (2015) 0.92

The Low FODMAP Diet and Its Application in East and Southeast Asia. J Neurogastroenterol Motil (2015) 0.91

Pathogenic role of the gut microbiota in gastrointestinal diseases. Intest Res (2016) 0.88

Efficacy of the low FODMAP diet for treating irritable bowel syndrome: the evidence to date. Clin Exp Gastroenterol (2016) 0.87

Lactose Intolerance in Adults: Biological Mechanism and Dietary Management. Nutrients (2015) 0.86

Novel perspectives on therapeutic modulation of the gut microbiota. Therap Adv Gastroenterol (2016) 0.86

Gut microbiota role in irritable bowel syndrome: New therapeutic strategies. World J Gastroenterol (2016) 0.85

Effects of high doses of vitamin D3 on mucosa-associated gut microbiome vary between regions of the human gastrointestinal tract. Eur J Nutr (2015) 0.84

The gastrointestinal tract microbiome, probiotics, and mood. Inflammopharmacology (2014) 0.84

Management of gastrointestinal involvement in scleroderma. Curr Treatm Opt Rheumatol (2015) 0.84

Recent developments in the pathophysiology of irritable bowel syndrome. World J Gastroenterol (2015) 0.84

Low serum levels of short-chain fatty acids after lactulose ingestion may indicate impaired colonic fermentation in patients with irritable bowel syndrome. Clin Exp Gastroenterol (2015) 0.83

A Randomized Controlled Trial Comparing the Low FODMAP Diet vs. Modified NICE Guidelines in US Adults with IBS-D. Am J Gastroenterol (2016) 0.82

Diet in irritable bowel syndrome. Nutr J (2015) 0.81

Consistent Prebiotic Effect on Gut Microbiota With Altered FODMAP Intake in Patients with Crohn's Disease: A Randomised, Controlled Cross-Over Trial of Well-Defined Diets. Clin Transl Gastroenterol (2016) 0.79

Probiotics, fibre and herbal medicinal products for functional and inflammatory bowel disorders. Br J Pharmacol (2016) 0.78

Current and emergent pharmacologic treatments for irritable bowel syndrome with diarrhea: evidence-based treatment in practice. Therap Adv Gastroenterol (2016) 0.78

Follow-up of patients with functional bowel symptoms treated with a low FODMAP diet. World J Gastroenterol (2016) 0.78

The Low FODMAP Diet: Many Question Marks for a Catchy Acronym. Nutrients (2017) 0.78

Gut microbiota and colorectal cancer. Eur J Clin Microbiol Infect Dis (2017) 0.78

The Gluten-Free/Casein-Free Diet: A Double-Blind Challenge Trial in Children with Autism. J Autism Dev Disord (2016) 0.77

Mucosa-associated microbiota signature in colorectal cancer. Eur J Clin Microbiol Infect Dis (2017) 0.77

Involvement of Reduced Microbial Diversity in Inflammatory Bowel Disease. Gastroenterol Res Pract (2016) 0.76

Addressing the Role of Food in Irritable Bowel Syndrome Symptom Management. J Nurse Pract (2016) 0.76

Faecal short-chain fatty acids - a diagnostic biomarker for irritable bowel syndrome? BMC Gastroenterol (2016) 0.76

Visceral hypersensitive rats share common dysbiosis features with irritable bowel syndrome patients. World J Gastroenterol (2016) 0.75

Influence of diet on the gut microbiome and implications for human health. J Transl Med (2017) 0.75

Gluten free diet is a cure not a poison! Gastroenterol Hepatol Bed Bench (2015) 0.75

Systematic review and meta-analysis: the effects of fermented milk with Bifidobacterium lactis CNCM I-2494 and lactic acid bacteria on gastrointestinal discomfort in the general adult population. Therap Adv Gastroenterol (2016) 0.75

Food, fibre, bile acids and the pelvic floor: An integrated low risk low cost approach to managing irritable bowel syndrome. World J Gastroenterol (2015) 0.75

Intestinal Microbiome, Akkermansia muciniphila, and Medical Nutrition Therapy. Integr Med (Encinitas) (2016) 0.75

Controversies and Recent Developments of the Low-FODMAP Diet. Gastroenterol Hepatol (N Y) (2017) 0.75

Host-microbial Cross-talk in Inflammatory Bowel Disease. Immune Netw (2017) 0.75

Possible therapeutic role of IgE blockade in irritable bowel syndrome. World J Gastroenterol (2016) 0.75

High-Fat Diet, Dysbiosis, and Gastrointestinal and Colonic Transit: Is There a Missing Link? Cell Mol Gastroenterol Hepatol (2016) 0.75

Diet in irritable bowel syndrome: What to recommend, not what to forbid to patients! World J Gastroenterol (2017) 0.75

Irritable Bowel Syndrome: A gut microbiota-related disorder? Am J Physiol Gastrointest Liver Physiol (2016) 0.75

Therapeutic Modulation of Gut Microbiota in Functional Bowel Disorders. J Neurogastroenterol Motil (2017) 0.75

Optimal management of constipation associated with irritable bowel syndrome. Ther Clin Risk Manag (2015) 0.75

Albumin gains immune boosting credibility. Clin Transl Gastroenterol (2015) 0.75

The Impact of Gastrointestinal Symptoms and Dermatological Injuries on Nutritional Intake and Hydration Status During Ultramarathon Events. Sports Med Open (2016) 0.75

Common Functional Gastroenterological Disorders Associated With Abdominal Pain. Mayo Clin Proc (2016) 0.75

Regulation of the serotonin transporter in the pathogenesis of irritable bowel syndrome. World J Gastroenterol (2016) 0.75

Irritable bowel syndrome, the microbiota and the gut-brain axis. Gut Microbes (2016) 0.75

Dairy and plant based food intakes are associated with altered faecal microbiota in 2 to 3 year old Australian children. Sci Rep (2016) 0.75

A Systematic Review of the Effects of Polyols on Gastrointestinal Health and Irritable Bowel Syndrome. Adv Nutr (2017) 0.75

Dietary Supplementation of Fermented Rice Bran Effectively Alleviates Dextran Sodium Sulfate-Induced Colitis in Mice. Nutrients (2017) 0.75

Bioelectrical impedance vector analysis in patients with irritable bowel syndrome on a low FODMAP diet: a pilot study. Tech Coloproctol (2017) 0.75

Effect of diet and individual dietary guidance on gastrointestinal endocrine cells in patients with irritable bowel syndrome (Review). Int J Mol Med (2017) 0.75

Microbiota-Brain-Gut Axis and Neurodegenerative Diseases. Curr Neurol Neurosci Rep (2017) 0.75

Close association between intestinal microbiota and irritable bowel syndrome. Eur J Clin Microbiol Infect Dis (2017) 0.75